Dulaglutide

Trade Name: 
Trulicity
Manufacturer/Distributor: 
Eli Lilly Canada
www.lilly.ca
Classification: 
Antihyperglycemic agent
ATC Class: 
A10BX - other blood glucose lowering drugs, excluding insulin
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2015/11/10
Date Marketed in Canada (yyyy/mm/dd): 
2016/01/08
Presentation: 
Solution for injection: 0.75 mg/0.5 mL. DIN: 02448599
Solution for injection: 1.5 mg/0.5 mL. DIN: 02448602
Comments: 
Dulaglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist given as a once weekly injection in adult patients with type 2 diabetes in combination with diet and exercise or with other antidiabetic drugs.